MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12974-021-02259-z

Медицинская библиотека · Journal of neuroinflammation · 2021

Anti-neuron antibody syndrome: clinical features, cytokines/chemokines and predictors.

Liao Shaohua, Li Chuanfen, Bi Xiaoying, Guo Hongwei, Qian Ying, Liu Xiaobei, Miao Shuai, Hu Huaiqiang, Cao Bingzhen

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Neuroimmunology is a rapidly expanding field, and there have been recent discoveries of new antibodies and neurological syndromes. Most of the current clinical studies have focused on disorders involving one specific antibody. We have summarized a class of antibodies that target common neuronal epitopes, and we have proposed the term "anti-neuron antibody syndrome" (ANAS). In this study, we aimed to clarify the clinical range and analyse the clinical features, cytokines/chemokines and predictors in ANAS.

METHODS

This was a retrospective cohort study investigating patients with neurological manifestations that were positive for anti-neuron antibodies.

RESULTS

A total of 110 patients were identified, of which 43 patients were classified as having autoimmune encephalitis (AE) and the other 67 were classified as having paraneoplastic neurological syndrome (PNS). With regards to anti-neuron antibodies, 42 patients tested positive for anti-N-methyl-D-aspartate receptor (NMDAR) antibody, 19 for anti-Hu, 14 for anti-Yo and 12 for anti-PNMA2 (Ma2). There were significant differences between the ANAS and control groups in serum B cell-activating factor (BAFF) levels and in cerebrospinal fluid (CSF) C-X-C motif chemokine10 (CXCL10), CXCL13, interleukin10 (IL10), BAFF and transforming growth factor β1 (TGFβ1) levels. Predictors of poor outcomes included having tumours (P = 0.0193) and having a chronic onset (P = 0.0306), and predictors of relapses included having lower levels of CSF BAFF (P = 0.0491) and having a larger ratio of serum TGFβ1/serum CXCL13 (P = 0.0182).

CONCLUSIONS

Most patients with ANAS had a relatively good prognosis. Having tumours and a chronic onset were both associated with poor outcomes. CSF BAFF and the ratio of serum TGFβ1/serum CXCL13 were associated with relapses.

Для цитирования: Liao Shaohua, Li Chuanfen, Bi Xiaoying, Guo Hongwei, Qian Ying, Liu Xiaobei, Miao Shuai, Hu Huaiqiang, Cao Bingzhen. Anti-neuron antibody syndrome: clinical features, cytokines/chemokines and predictors.. Journal of neuroinflammation. 2021. DOI: 10.1186/s12974-021-02259-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.